Avonex research

A board to discuss the Multiple Sclerosis modifying drug Avonex

Avonex research

Postby bromley » Thu Sep 28, 2006 1:15 pm

User avatar
Family Elder
Posts: 1887
Joined: Fri Sep 10, 2004 2:00 pm


Re: Avonex research

Postby NHE » Thu Sep 28, 2006 8:33 pm

"Adherence is a critical component in chronic disease treatment, directly impacting long-term efficacy. The GAP study suggests that AVONEX leads to superior adherence which may contribute to long-term effectiveness," said Bernd Kieseier, MD, Professor of Neurology, Heinrich-Heine-Universität, Düsseldorf, Germany, and a lead investigator in the project.

While the first half of the above statement cannot be argued with, i.e., in order for a treatment to be effective its dosing regimen must be adhered to, the second half of the above statement seems like too big of a logistical leap and is based on assumption. Although I have not read the original study, the news article does not discuss effectiveness. It only discusses adherence. One would need to compare the long term effectiveness of particular treatments in order to make the second statement. If the study had done that, then I'm sure they would be reporting that information though they don't.

User avatar
Volunteer Moderator
Posts: 3726
Joined: Sat Nov 20, 2004 3:00 pm

Postby Mechanicallyinclined » Sun Dec 27, 2009 1:01 pm

No doubt adherence will contribute to effectiveness. That's a no brainer.
Total effectiveness is what I wonder about. I know what the stats were on the drug when I started this therapy. I wonder honestly what the real effectivness is
User avatar
Family Elder
Posts: 128
Joined: Mon Dec 21, 2009 3:00 pm
Location: Manitoba Canada

Return to Avonex


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service